Yisi Daisy Ji, D.M.D., M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Surgery, Oral | 19 | 2023 | 146 | 9.110 |
Why?
|
Oral Surgical Procedures | 3 | 2021 | 168 | 1.360 |
Why?
|
Malpractice | 2 | 2020 | 569 | 0.950 |
Why?
|
Maxillofacial Injuries | 1 | 2023 | 33 | 0.910 |
Why?
|
Orbital Fractures | 1 | 2023 | 110 | 0.820 |
Why?
|
Medical Staff | 1 | 2020 | 43 | 0.740 |
Why?
|
Orthognathic Surgery | 1 | 2020 | 32 | 0.720 |
Why?
|
Dentistry | 1 | 2020 | 113 | 0.710 |
Why?
|
Mandibular Condyle | 1 | 2020 | 115 | 0.710 |
Why?
|
Anemia, Hemolytic, Autoimmune | 1 | 2021 | 142 | 0.690 |
Why?
|
Anesthesia | 2 | 2021 | 1548 | 0.680 |
Why?
|
Lip | 1 | 2020 | 195 | 0.680 |
Why?
|
Mandibular Neoplasms | 2 | 2016 | 129 | 0.680 |
Why?
|
Orthognathic Surgical Procedures | 1 | 2020 | 115 | 0.650 |
Why?
|
Mouth Neoplasms | 2 | 2021 | 601 | 0.650 |
Why?
|
Medicare | 7 | 2020 | 6532 | 0.630 |
Why?
|
Bupivacaine | 1 | 2021 | 408 | 0.610 |
Why?
|
Mouth Diseases | 1 | 2020 | 239 | 0.610 |
Why?
|
Anesthesia, Dental | 1 | 2018 | 67 | 0.610 |
Why?
|
Parotid Diseases | 1 | 2017 | 46 | 0.600 |
Why?
|
Conflict of Interest | 2 | 2020 | 542 | 0.570 |
Why?
|
Insurance, Dental | 1 | 2016 | 52 | 0.570 |
Why?
|
Head and Neck Neoplasms | 2 | 2020 | 2712 | 0.560 |
Why?
|
Industry | 1 | 2018 | 365 | 0.560 |
Why?
|
Bone Resorption | 1 | 2020 | 722 | 0.560 |
Why?
|
Reimbursement Mechanisms | 2 | 2019 | 670 | 0.550 |
Why?
|
Facial Nerve | 1 | 2017 | 271 | 0.500 |
Why?
|
Benchmarking | 1 | 2021 | 1038 | 0.490 |
Why?
|
Checklist | 2 | 2020 | 830 | 0.470 |
Why?
|
Anesthetics, Local | 1 | 2021 | 984 | 0.470 |
Why?
|
Stomatitis | 1 | 2016 | 269 | 0.470 |
Why?
|
Dental Implantation, Endosseous | 1 | 2016 | 502 | 0.440 |
Why?
|
Politics | 1 | 2018 | 790 | 0.410 |
Why?
|
Burnout, Professional | 1 | 2020 | 690 | 0.400 |
Why?
|
Medically Uninsured | 1 | 2016 | 852 | 0.380 |
Why?
|
Pain, Postoperative | 1 | 2021 | 1638 | 0.380 |
Why?
|
Suicide | 1 | 2020 | 1475 | 0.350 |
Why?
|
Laparoscopy | 1 | 2021 | 2121 | 0.340 |
Why?
|
General Surgery | 1 | 2020 | 1633 | 0.330 |
Why?
|
Medical Errors | 1 | 2017 | 1296 | 0.330 |
Why?
|
Students, Medical | 1 | 2021 | 1858 | 0.330 |
Why?
|
Dental Implants | 1 | 2016 | 749 | 0.320 |
Why?
|
Faculty, Dental | 2 | 2018 | 60 | 0.310 |
Why?
|
Burning Mouth Syndrome | 2 | 2017 | 31 | 0.300 |
Why?
|
Clonazepam | 2 | 2017 | 136 | 0.300 |
Why?
|
Databases, Factual | 2 | 2018 | 7716 | 0.280 |
Why?
|
Humans | 44 | 2023 | 742088 | 0.270 |
Why?
|
Internship and Residency | 2 | 2022 | 5774 | 0.250 |
Why?
|
Analgesics, Opioid | 1 | 2021 | 3667 | 0.250 |
Why?
|
Operating Rooms | 2 | 2021 | 813 | 0.250 |
Why?
|
Cross-Sectional Studies | 9 | 2021 | 24913 | 0.240 |
Why?
|
United States | 15 | 2020 | 69693 | 0.240 |
Why?
|
Immunosuppressive Agents | 1 | 2016 | 4147 | 0.230 |
Why?
|
Retrospective Studies | 12 | 2023 | 77098 | 0.200 |
Why?
|
Societies, Dental | 2 | 2018 | 33 | 0.200 |
Why?
|
Kidney Transplantation | 1 | 2016 | 4246 | 0.200 |
Why?
|
Administration, Topical | 3 | 2017 | 688 | 0.190 |
Why?
|
Health Services Accessibility | 1 | 2018 | 5133 | 0.190 |
Why?
|
Practice Guidelines as Topic | 1 | 2018 | 7276 | 0.190 |
Why?
|
Orbit | 1 | 2023 | 427 | 0.180 |
Why?
|
Current Procedural Terminology | 1 | 2020 | 92 | 0.180 |
Why?
|
Compensation and Redress | 1 | 2018 | 71 | 0.150 |
Why?
|
Health Policy | 2 | 2022 | 2657 | 0.150 |
Why?
|
Liposomes | 1 | 2021 | 758 | 0.150 |
Why?
|
Clobetasol | 1 | 2016 | 34 | 0.140 |
Why?
|
Ameloblastoma | 1 | 2016 | 41 | 0.140 |
Why?
|
Placebos | 1 | 2021 | 1677 | 0.140 |
Why?
|
Paresthesia | 1 | 2017 | 162 | 0.140 |
Why?
|
Students, Dental | 1 | 2018 | 160 | 0.140 |
Why?
|
Neck | 1 | 2020 | 693 | 0.130 |
Why?
|
Mandible | 1 | 2020 | 740 | 0.130 |
Why?
|
Gels | 1 | 2016 | 427 | 0.130 |
Why?
|
Dental Care | 1 | 2018 | 262 | 0.130 |
Why?
|
Arthroplasty, Replacement | 1 | 2019 | 336 | 0.130 |
Why?
|
Authorship | 1 | 2018 | 271 | 0.130 |
Why?
|
Respiratory Tract Infections | 1 | 2022 | 959 | 0.120 |
Why?
|
Quality-Adjusted Life Years | 1 | 2020 | 1679 | 0.120 |
Why?
|
Face | 1 | 2020 | 993 | 0.120 |
Why?
|
Truth Disclosure | 1 | 2018 | 435 | 0.120 |
Why?
|
Physician's Role | 1 | 2020 | 942 | 0.110 |
Why?
|
Learning | 1 | 2021 | 1705 | 0.100 |
Why?
|
Preoperative Care | 1 | 2021 | 2245 | 0.100 |
Why?
|
Young Adult | 4 | 2023 | 56350 | 0.100 |
Why?
|
Ambulatory Care Facilities | 1 | 2018 | 932 | 0.100 |
Why?
|
Residence Characteristics | 1 | 2021 | 2049 | 0.100 |
Why?
|
Pain Measurement | 1 | 2021 | 3418 | 0.100 |
Why?
|
Female | 13 | 2020 | 379592 | 0.100 |
Why?
|
Middle Aged | 9 | 2023 | 213127 | 0.100 |
Why?
|
Adolescent | 5 | 2023 | 85649 | 0.090 |
Why?
|
Cooperative Behavior | 1 | 2018 | 1503 | 0.090 |
Why?
|
Male | 12 | 2021 | 349538 | 0.090 |
Why?
|
Papillomavirus Infections | 1 | 2022 | 1585 | 0.090 |
Why?
|
Rural Population | 1 | 2020 | 2207 | 0.090 |
Why?
|
Health Services Research | 1 | 2017 | 1834 | 0.080 |
Why?
|
Health Personnel | 1 | 2021 | 3210 | 0.070 |
Why?
|
Hospitals | 1 | 2021 | 3937 | 0.070 |
Why?
|
Aged | 7 | 2020 | 162944 | 0.070 |
Why?
|
Treatment Outcome | 4 | 2021 | 62966 | 0.070 |
Why?
|
Medical Oncology | 1 | 2018 | 2235 | 0.070 |
Why?
|
Postoperative Complications | 2 | 2021 | 15244 | 0.070 |
Why?
|
Anti-Inflammatory Agents | 1 | 2016 | 1788 | 0.070 |
Why?
|
Quality Assurance, Health Care | 1 | 2017 | 2211 | 0.070 |
Why?
|
Patient Care Team | 1 | 2018 | 2527 | 0.070 |
Why?
|
Longitudinal Studies | 1 | 2020 | 13921 | 0.060 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2021 | 9941 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 7901 | 0.060 |
Why?
|
Child | 2 | 2023 | 77478 | 0.060 |
Why?
|
Telemedicine | 1 | 2020 | 2853 | 0.060 |
Why?
|
Adult | 7 | 2023 | 213712 | 0.060 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3130 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3236 | 0.050 |
Why?
|
Diagnosis, Differential | 1 | 2016 | 12958 | 0.050 |
Why?
|
Aged, 80 and over | 3 | 2021 | 57683 | 0.050 |
Why?
|
Pandemics | 1 | 2020 | 8328 | 0.040 |
Why?
|
Risk Assessment | 1 | 2020 | 23320 | 0.040 |
Why?
|
Diagnosis-Related Groups | 1 | 2020 | 454 | 0.040 |
Why?
|
Mouthwashes | 1 | 2017 | 59 | 0.040 |
Why?
|
Solutions | 1 | 2017 | 426 | 0.040 |
Why?
|
Efficiency | 1 | 2020 | 462 | 0.040 |
Why?
|
Frozen Sections | 1 | 2016 | 155 | 0.030 |
Why?
|
Organizational Objectives | 1 | 2017 | 438 | 0.030 |
Why?
|
Risk Factors | 1 | 2020 | 72145 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2019 | 2536 | 0.030 |
Why?
|
Vulnerable Populations | 1 | 2018 | 685 | 0.030 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2022 | 2940 | 0.030 |
Why?
|
Neoplasm, Residual | 1 | 2016 | 974 | 0.030 |
Why?
|
Costs and Cost Analysis | 1 | 2017 | 1679 | 0.020 |
Why?
|
Program Evaluation | 1 | 2018 | 2485 | 0.020 |
Why?
|
Communication | 1 | 2020 | 3728 | 0.020 |
Why?
|
Sex Factors | 1 | 2019 | 10392 | 0.020 |
Why?
|
Biopsy | 1 | 2016 | 6756 | 0.020 |
Why?
|
Lung | 1 | 2022 | 9826 | 0.010 |
Why?
|
Prognosis | 1 | 2021 | 29010 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2016 | 9185 | 0.010 |
Why?
|